Spire Healthcare Group Plc on Wednesday held guidance and said it expected no hit to its supply chain from US tariffs.
The company said trading in the first four months of the year had been in line with expectations.
"Furthermore, our on-going transformation programme, which is expected to deliver at least £30m in efficiencies during FY25, remains on track with benefits weighted towards the second half of the year," it added in a trading statement.
"As a business with 100% direct UK revenue exposure, we do not currently anticipate any material cost or supply chain impacts as a result of recent tariff announcements."
Reporting by Frank Prenesti for Sharecast.com